Ciguatera fish poisoning (CFP) is the most common nonbacterial seafood-borne illness worldwide, caused by consumption of reef fish contaminated with ciguatoxins produced by the dinoflagellate Gambierdiscus toxicus. [1] Diagnosis is entirely clinical — there is no confirmatory laboratory test — and hinges on the combination of GI + neurologic symptoms after reef fish ingestion, with cold allodynia being nearly pathognomonic. [1-2]
1. History
- Key HPI: What type of fish was eaten? Where was it caught? How large was the fish? When was it consumed relative to symptom onset?
- Timing: Symptoms typically begin 3–6 hours after ingestion but can be delayed up to 30 hours; GI symptoms appear first, followed by neurologic symptoms over 24 hours [1-2]
- Symptom characterization: Ask specifically about nausea, vomiting, diarrhea, abdominal cramping, then paresthesias, perioral numbness, "burning" on touching cold objects, metallic taste, loose-tooth sensation, pruritus, myalgias, arthralgias, fatigue [1-2]
- Important negatives: Fever (absent in CFP — its presence suggests bacterial etiology), rash, dyspnea, focal weakness, altered mental status
- Travel history: Recent travel to tropical/subtropical regions (Caribbean, Pacific, Indian Ocean); also consider imported fish in non-endemic areas [3-4]
- Co-ingestants: Others who ate the same fish (cluster cases are common) [5]
2. Alarm Features
- Symptomatic bradycardia or heart block [1][6]
- Hypotension or cardiovascular collapse [1]
- Coma (rare but reported) [7]
- Severe dehydration from profuse vomiting/diarrhea
- Respiratory distress (rare; suggests severe toxin load or alternative diagnosis)
- Rapidly progressive neurologic deficits — consider Guillain-Barré syndrome as a mimic [2]
3. Medications
Acute treatment (all supportive — no specific antidote exists): [1][8]
- IV fluids and electrolyte repletion for GI losses
- Atropine for symptomatic bradycardia
- IV mannitol (1 g/kg over 30–45 min): historically used, but the only RCT showed no benefit over normal saline; may be considered in acute cases within 48 hours if the patient is hemodynamically stable and well-hydrated [1][8-9]
- Activated charcoal: consider if early presentation and not vomiting [1]
- Antiemetics (ondansetron) for nausea/vomiting
- Antihistamines (diphenhydramine, hydroxyzine) for pruritus [1]
Chronic/neuropathic symptom management: [1][8]
- Gabapentin or pregabalin for persistent paresthesias
- Amitriptyline for chronic paresthesia and depression
- Fluoxetine for chronic fatigue
- Nifedipine or acetaminophen for headaches
Contraindicated/cautions
- Avoid opioids if possible (may worsen hypotension/bradycardia)
- Mannitol is contraindicated in hemodynamically unstable or dehydrated patients [1]
4. Diet
- After recovery, advise patients to avoid fish, alcohol, caffeine, and nuts for ≥6 months — these can trigger symptom relapse [1-2]
- Adequate hydration is critical during the acute phase
- No specific acute dietary intervention beyond NPO if actively vomiting
- Long-term: educate on avoidance of large carnivorous reef fish (>5 lbs), especially barracuda, grouper, amberjack, moray eel [1]
5. Review of Systems
- GI: Nausea, vomiting, diarrhea, abdominal pain
- Neurologic: Paresthesias (perioral, hands, feet), cold allodynia, metallic taste, dental pain/loose-tooth sensation, headache, dizziness, ataxia, blurred vision [1-2]
- Psychiatric: Depression, anxiety, nightmares, impaired memory, chronic fatigue [1-2]
- Cardiovascular: Palpitations, lightheadedness, syncope [1][6]
- Dermatologic: Generalized pruritus, diaphoresis, rash [2]
- GU: Dysuria, painful intercourse (reported in case series) [5]
- MSK: Myalgias, arthralgias (especially knees, ankles, shoulders) [2]
6. Collateral History and Family History
- Critical: Did anyone else eat the same fish? Cluster cases strongly support the diagnosis [4-5]
- Obtain details from dining companions about the fish species, size, source, and preparation
- Family history is not directly relevant (CFP is not hereditary)
- Prior CFP episodes: Patients with previous exposure may experience sensitization — more rapid onset and more severe symptoms with re-exposure [2]
7. Risk Factors
- Consumption of large carnivorous reef fish (barracuda, grouper, amberjack, moray eel, sea bass, snapper) [1]
- Fish weighing >5 lbs carry higher toxin loads [1]
- Eating high-risk parts: head, liver, intestines, roe (toxin concentrates here) [1]
- Travel to or fish imported from tropical/subtropical waters (Caribbean, Pacific, Indian Ocean) between latitudes 35°N and 35°S [1]
- Increasing risk with coral reef degradation due to climate change [1]
- Prior CFP episode (sensitization risk) [2]
8. Differential Diagnosis
- Scombroid fish poisoning: Histamine-mediated; flushing, urticaria, rapid onset (<1 hr); responds to antihistamines; no cold allodynia
- Paralytic shellfish poisoning (PSP): Shellfish ingestion; rapid-onset paresthesias and paralysis; no GI predominance
- Tetrodotoxin poisoning (pufferfish): Rapid ascending paralysis, respiratory failure; pufferfish ingestion history
- Guillain-Barré syndrome: Ascending weakness/areflexia; must be considered if motor symptoms predominate [2]
- Bacterial gastroenteritis (Vibrio, Salmonella): Fever present; no neurologic symptoms
- Organophosphate poisoning: Cholinergic toxidrome (SLUDGE); different exposure history
- Botulism: Descending paralysis, cranial nerve involvement, no sensory symptoms
- Neurotoxic shellfish poisoning (brevetoxin): Similar GI + neuro picture but from shellfish; associated with red tide
Key distinguishing feature: The combination of GI symptoms + cold allodynia after reef fish ingestion is virtually diagnostic of CFP [1-2]
9. Past Medical History
- Prior CFP episodes: Increases risk of sensitization and more severe recurrence [2]
- Cardiac history: Pre-existing bradycardia, heart block, or use of beta-blockers/calcium channel blockers may compound cardiovascular toxicity
- Hepatic/renal disease: May affect toxin clearance and medication dosing
- Psychiatric history: CFP can exacerbate depression and anxiety [1]
10. Physical Exam
Vital signs
- Bradycardia (may be significant) [1][6]
- Hypotension (orthostatic or frank) [1]
- Temperature typically normal (fever suggests alternative diagnosis)
Focused exam
- Neurologic: Sensory exam — test for cold allodynia (apply cold object to skin; patient reports burning pain), pin-prick and light touch in glove-and-stocking distribution, vibration sense, deep tendon reflexes (areflexia in ~10%), cerebellar signs (rare) [2]
- Abdominal: Diffuse tenderness, hyperactive bowel sounds; no peritoneal signs
- Skin: Generalized excoriations from pruritus, diaphoresis
- Cardiovascular: Bradycardia, irregular rhythm if heart block present
11. Lab Studies
- No specific diagnostic test exists for ciguatoxin in humans [1-2]
- Labs are used to rule out alternative diagnoses and assess complications:
- BMP/CMP: Electrolytes (dehydration, hypokalemia from vomiting/diarrhea), renal function, glucose
- CBC: Leukocytosis suggests infectious etiology
- Hepatic panel: If considering other toxin exposures
- Lactate: If hemodynamically unstable
- Troponin: If significant bradycardia or cardiovascular symptoms
- Stool studies: If bacterial gastroenteritis is in the differential
- Monitoring: Serial electrolytes and renal function if significant fluid losses
12. Imaging
- Imaging is generally unnecessary for straightforward CFP presentations
- Abdominal imaging (CT abdomen/pelvis): Only if peritoneal signs or concern for surgical abdomen
- Chest X-ray: If respiratory symptoms present
- Brain MRI: Consider only if atypical neurologic findings (focal deficits, altered mental status) to rule out stroke or CNS pathology
- Nerve conduction studies/EMG: May be considered in chronic cases with persistent neuropathy to characterize the polyneuropathy [2]
13. Special Tests
- Cold allodynia provocation test: Apply ice or cold water to skin — burning dysesthesia is nearly pathognomonic [2][8]
- Dry ice test: Alternative cold stimulus for bedside testing
- No validated point-of-care test for ciguatoxin in patients [1-2]
- Fish testing for ciguatoxin exists (immunoassay, cell-based assays) but is rarely available clinically and the implicated fish is usually consumed [2]
- Poison Control consultation: Recommended for all suspected cases (1-800-222-1222 in the US)
14. ECG
- Obtain ECG in all patients with suspected CFP, particularly if cardiovascular symptoms are present
- Findings to look for:
- Sinus bradycardia (most common cardiovascular finding) [1][6][10]
- Heart block (first-degree, second-degree, or rarely third-degree) [1]
- Hypotension-related changes
- T-wave abnormalities (nonspecific)
- Continuous cardiac monitoring if bradycardia or conduction abnormalities are present
15. Assessment
- CFP is a clinical diagnosis based on the triad of: (1) recent reef fish consumption, (2) GI symptoms, and (3) characteristic neurologic findings, especially cold allodynia [1-2]
- Severity stratification:
- Mild: GI symptoms ± mild paresthesias, hemodynamically stable
- Moderate: Prominent neurologic symptoms, mild bradycardia, orthostatic hypotension
- Severe: Significant bradycardia/heart block, hypotension requiring vasopressors, coma (rare) [7]
- Mortality is <0.1% but varies with toxin dose and access to care [1]
- Chronic course: Neurologic symptoms persist in ~40% at 2 weeks; can last months to years [2][10]
- Atypical presentations: May present in non-endemic areas due to imported fish; GI-predominant (Caribbean) vs. neuro-predominant (Pacific) regional variation [2][4]
16. Treatment Plan
Initial stabilization
- ABCs; IV access; continuous cardiac monitoring
- IV crystalloid bolus for dehydration/hypotension [1]
Acute management
- Antiemetics (ondansetron 4 mg IV) for vomiting
- Atropine 0.5–1 mg IV for symptomatic bradycardia; may repeat [1]
- Alpha-adrenergic agonists (e.g., phenylephrine) if hypotension refractory to fluids [1]
- Activated charcoal (50 g PO) if within 1–2 hours of ingestion and patient is not vomiting [1]
- IV mannitol (1 g/kg over 30–45 min): controversial; evidence is low quality; consider in acute cases (<48 hrs) with significant neurologic symptoms if hemodynamically stable [1][8-9]
- Antihistamines for pruritus [1]
Chronic symptom management
- Gabapentin 300–600 mg TID or pregabalin for persistent neuropathic symptoms [1][8]
- Amitriptyline 25–75 mg QHS for chronic paresthesias/depression [1-2][8]
- Fluoxetine for chronic fatigue [1]
Patient education
17. Disposition
Admission criteria
- Hemodynamic instability (significant bradycardia, hypotension)
- Heart block on ECG
- Severe dehydration unresponsive to initial fluid resuscitation
- Altered mental status or coma
- Inability to tolerate oral fluids
- Severe neurologic symptoms (ataxia, significant weakness)
Observation indications
- Moderate bradycardia responding to atropine
- Ongoing GI losses requiring IV hydration
- Monitoring after mannitol administration
Discharge criteria
- Hemodynamically stable with normal heart rate
- Tolerating oral fluids
- Mild-to-moderate neurologic symptoms (paresthesias, pruritus) without cardiovascular compromise
- Reliable follow-up and understanding of return precautions
Specialist consultation triggers
- Cardiology: Persistent bradycardia or heart block
- Toxicology/Poison Control: All cases (for reporting and management guidance)
- Neurology: Persistent or worsening neuropathy beyond 4–6 weeks
18. Follow Up / Return Precautions
Follow-up timing
- Primary care follow-up within 3–5 days for mild cases
- Earlier follow-up (24–48 hrs) if discharged with ongoing symptoms
- Neurology referral if symptoms persist beyond 4–6 weeks
Return to ED immediately for
- Worsening weakness or difficulty walking
- Chest pain, palpitations, syncope, or near-syncope
- Inability to keep fluids down
- Shortness of breath
- Confusion or altered mental status
Patient counseling
- Neurologic symptoms (paresthesias, cold allodynia, fatigue) commonly persist for weeks to months and may fluctuate — this is expected [1-2][10]
- Strict dietary avoidance: No fish, alcohol, caffeine, or nuts for at least 6 months to prevent relapse [1]
- Future fish consumption: Permanently avoid barracuda and moray eel; avoid large reef fish (>5 lbs); avoid fish head, liver, intestines, and roe [1]
- Report cases to local/state health department for surveillance [4-5]
- Sensitization: Prior CFP increases susceptibility to future episodes [2]
References
1. Food Poisoning from Marine Toxins. — Vernon E. Ansdell CDC Yellow Book. 2025.
2. Neurotoxic Marine Poisoning. — Isbister GK, Kiernan MC. The Lancet. Neurology. 2005.
3. A Curious Case of Ciguatera Fish Poisoning in the Midwest and a Review for Clinicians. — Patel M, Jutzy K. The Journal of Emergency Medicine. 2020.
4. Ciguatera Fish Poisoning--Texas, 1998, and South Carolina, 2004. — MMWR. Morbidity and Mortality Weekly Report. 2006.
5. Cluster of Ciguatera Fish Poisoning--North Carolina, 2007. — MMWR. Morbidity and Mortality Weekly Report. 2009.
6. Epidemiology and Clinical Features of Ciguatera Fish Poisoning in Hong Kong. — Chan TY. Toxins. 2014.
7. Successful Treatment of Ciguatera Fish Poisoning With Intravenous Mannitol. — Palafox NA, Jain LG, Pinano AZ, et al. The Journal of the American Medical Association. 1988.
8. Is Mannitol the Treatment of Choice for Patients With Ciguatera Fish Poisoning?. — Mullins ME, Hoffman RS. Clinical Toxicology. 2017.
9. Ciguatera Fish Poisoning: A Double-Blind Randomized Trial of Mannitol Therapy. — Schnorf H, Taurarii M, Cundy T. Neurology. 2002.
10. Clinical Characteristics of Ciguatera Poisoning in Martinique, French West Indies-a Case Series. — Résière D, Florentin J, Mehdaoui H, et al. Toxins. 2022.